• /search
  • Servizi
  • Crea un podcast
  • Spreaker
  • Piani e prezzi
  • Ascolta
  • Accedi Registrati
  • Distribuzione
  • Monetizzazione podcast
  • Statistiche per i podcast
  • Podcasting per aziende
  • App di registrazione
  • App per l’ascolto
  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Scopri di più
  • Servizi
    • Distribuzione
    • Monetizzazione podcast
    • Statistiche per i podcast
    • Podcasting per aziende
    • App di registrazione
    • App per l’ascolto
  • Crea un podcast
  • Piani e prezzi
  • Ascolta
    • Featured This Week
    • Spreaker's Prime Shows
    • Staff Picks
    • Crime
    • This NFL life 🏈
    • Scopri di più
  • Registrati SIGN IN
← Esplora

#histology

Tag collegati:

#grace #nsclc #cancergrace #molecular #oncology
  • Dr. Lecia Sequist: Can We Bring The Advances in Targeted Therapy to Squamous NSCLC and Broader NSCLC Populations?

    Dr. Lecia Sequist: Can We B...

  • Dr. Heather Wakelee: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Heather Wakelee: My App...

  • Dr. Geoffrey Oxnard on Translating the Benefits of Molecular Oncology More Broadly: The Tissue is the Issue

    Dr. Geoffrey Oxnard on Tran...

  • Highlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy (video)

    Highlights in Lung Cancer, ...

  • Dr. Lecia Sequist: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. Lecia Sequist: Will New...

  • Dr. Sarah Goldberg: What Methods Do I Use to Obtain Samples for Molecular Testing?

    Dr. Sarah Goldberg: What Me...

  • Dr. Karen Reckamp on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Dr. Karen Reckamp on "...

  • Dr. Larry Einhorn: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. Larry Einhorn: Will New...

  • Dr. Geoffrey Oxnard: Are Patients or Payers Objecting to Repeat Biopsy?

    Dr. Geoffrey Oxnard: Are Pa...

  • Dr. David Spigel: Which Lung Cancer Patients Should We Be Doing Molecular Marker Testing For, and Should We Do "Reflex Testing"?

    Dr. David Spigel: Which Lun...

  • Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Drs. Ross Camidge and Corey...

  • Dr. Geoffrey Oxnard: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing

    Dr. Geoffrey Oxnard: For Wh...

  • Dr. David Spigel: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. David Spigel: My Approa...

  • Dr. Sarah Goldberg on "Which molecular marker tests do you seek?"

    Dr. Sarah Goldberg on &quot...

  • Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for?"

    Drs. Ross Camidge and Corey...

  • Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Greg Riely: My Approach...

  • Dr. Rosalyn Juergens: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. Rosalyn Juergens: Will ...

  • Drs. Ross Camidge and Corey Langer: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Drs. Ross Camidge and Corey...

  • Dr. Bob Doebele: Will We Be Able to Use Molecular Markers and Apply Targeted Therapies to Broader Lung Cancer Subtypes in the Near Future?

    Dr. Bob Doebele: Will We Be...

  • Dr. Greg Riely: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. Greg Riely: Will New Fo...

  • What Molecular Markers Do You Prioritize for Molecular Testing in Advanced NSCLC, and Who do you Test?

    What Molecular Markers Do Y...

  • Dr. Heather Wakelee on "Which molecular marker tests do you seek?"

    Dr. Heather Wakelee on &quo...

  • Dr. Ravi Salgia on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Dr. Ravi Salgia on "Wh...

  • Highlights in Lung Cancer, 2013, Part 4: Squamous Cell NSCLC and antiPD1 Immunotherapy  (audio)

    Highlights in Lung Cancer, ...

  • Dr. Karen Kelly: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Karen Kelly: My Approac...

  • Dr. Ravi Salgia: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?

    Dr. Ravi Salgia: For Which ...

  • Dr. David Spigel: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. David Spigel: Will New ...

  • Dr. Phil Bonomi: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?

    Dr. Phil Bonomi: For Which ...

  • Dr. Sarah Goldberg on "Which patients do you send molecular marker testing for?"

    Dr. Sarah Goldberg on &quot...

  • Dr. Karen Kelly: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

    Dr. Karen Kelly: Will New F...

  • Dr. David Spigel on "Which molecular marker tests do you seek?"

    Dr. David Spigel on "W...

  • Dr. Greg Riely on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Dr. Greg Riely on "Whi...

  • Different Lung Cancer Subtypes - Histology

    Different Lung Cancer Subty...

  • What is the Role of Bevacizumab in Stage IV NSCLC?

    What is the Role of Bevaciz...

  • Histology-Specific Regimens - Adenocarcinoma

    Histology-Specific Regimens...

  • Histology-Specific Regimens - Squamous

    Histology-Specific Regimens...

  • Histology-Specific Recommendations - Large-Cell Neuroendocrine

    Histology-Specific Recommen...

  • Anatomic Pathology with Dr. Joanna Walsh

    Anatomic Pathology with Dr....

Altro Sto caricando
Spreaker logo
  • Piani e prezzi
  • Voxnest
  • Blog
  • Lavora con noi
  • Press
  • Scegli una lingua

Per podcaster ed editori

  • Podcasting per aziende
  • Monetizzazione podcast
  • Statistiche per i podcast
  • Distribuzione

Strumenti per i podcaster

  • Come creare un podcast
  • Store di Spreaker
  • App Studio di Spreaker
  • Centro assistenza

Per gli ascoltatori

  • App Podcast di Spreaker

Other Pages

  • Termini
  • Privacy
  • Do Not Sell My Information

Categorie principali

  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Scopri di più

Categorie principali

  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Scopri di più

Seguici su

  • Icona di Facebook Facebook
  • Icona di Twitter Twitter
  • Icona di LinkedIn LinkedIn
  • Icona di Instagram Instagram
Marchio soci IAB

    Other Pages

  • Termini
  • Privacy
  • Do Not Sell My Information

Seguici su

Icona di Facebook Facebook
Icona di Twitter Twitter
Icona di LinkedIn LinkedIn
Icona di Instagram Instagram
iAB member
Copyright 2021 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Privacy
Termini
Do Not Sell My Information